Atlas Trials

Regulatory PMS Study for Lucentis® in Patients With Retinopathy of Prematurity

Clinical trial NCT05304949 · COMPLETED

Trial details

NCT number
NCT05304949
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Study type
OBSERVATIONAL
Retinopathy of Prematurity
Start date
2022-06-22
Primary completion
2025-01-11
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.